Ensysce Biosciences CFO David Humphrey's 2022 pay jumps 175% to $781K
Ensysce Biosciences reports 2022 executive compensation
By ExecPay News
Published: July 13, 2023
Ensysce Biosciences reported fiscal year 2022 executive compensation information on July 13, 2023.
In 2022, four executives at Ensysce Biosciences received on average a compensation package of $638K, a 171% increase compared to previous year.
Average pay of disclosed executives at Ensysce Biosciences
David Humphrey, Chief Financial Officer, received $781K in total, which increased by 175% compared to 2021. 56% of Humphrey's compensation, or $439K, was in option awards. Humphrey also received $328K in salary and $14K in other compensation.
Dave Humphrey, Chief Financial Officer, received a compensation package of $781K. 56% of the compensation package, or $439K, was in option awards.
Lynn Kirkpatrick, Chief Executive Officer, earned $623K in 2022, a 116% increase compared to previous year.
Geoff Birkett, Chief Commercial Officer, received $367K in 2022, which increases by 172% compared to 2021.
Related executives
You may also like
Source: SEC filing on July 13, 2023.